Profile of drug-resistant mutations in nucleos(t)ide analogue-experienced chronic hepatitis B patients in Tianjin, China

We read with great interest the recent study by Guo et  al [1] in this journal that aimed at evaluating the dynamic changes of the mutation patterns of hepatitis B virus resistance to nucleos(t)ide analogs (NAs) in North China. However, profile of HBV resistance mutations against NAs treatment in patients with chronic hepatitis B infection in Tianjin, the biggest coastal city in northern China with a population of more than 14 million, is still largely unknown. Therefore, we want to contribute by reporting the drug-resistant mutations in NAs-experienced chronic hepatitis B patients in Tianjin, China.
Source: International Journal of Antimicrobial Agents - Category: Drugs & Pharmacology Authors: Tags: Letter to the Editor Source Type: research